In The Spotlight

STEM – Stem Cells, Inc.

StemCells, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cell-based therapeutics to treat diseases of the central nervous system and liver. The company engages in product development programs for two cell types: the human neural stem cell and human liver engrafting cells. The company was founded in 1988 and is headquartered in Palo Alto, California. Stem Cells, Inc. ended the day trading on Friday at $1.36 up $0.18 or 15.25 percent on 6.18 million volume. In after hours trading STEM closed up $0.05 or 3.68 percent at $1.41. Please have a close look at the chart below.